Radiofrequency Ablation of Renal Transitional Cell Carcinoma with Protective Cold Saline Infusion Dietrich Schultze, MD, Christopher S. Morris, MD, Anant D. Bhave, MD, Barbara A. Worgan, RN, NP-C, Kenneth E. Najarian, MD Journal of Vascular and Interventional Radiology Volume 14, Issue 4, Pages 489-492 (April 2003) DOI: 10.1097/01.RVI.0000064852.87207.0B Copyright © 2003 Society of Interventional Radiology Terms and Conditions
Figure 1 Nephrostography, performed with the patient prone, demonstrates a large irregular mass, which represents the transitional cell carcinoma, in the ureteropelvic junction of the left kidney (arrows). Journal of Vascular and Interventional Radiology 2003 14, 489-492DOI: (10.1097/01.RVI.0000064852.87207.0B) Copyright © 2003 Society of Interventional Radiology Terms and Conditions
Figure 2 AP radiography, performed with the patient prone, shows the triple-cluster RF ablation probe with the tips located in the region of the tumor in the ureteropelvic junction of the left kidney. Journal of Vascular and Interventional Radiology 2003 14, 489-492DOI: (10.1097/01.RVI.0000064852.87207.0B) Copyright © 2003 Society of Interventional Radiology Terms and Conditions
Figure 3 Follow-up nephrostography at 4 weeks shows significant decrease in the size of the tumor in the ureteropelvic junction of the left kidney and a widely patent collecting system without leakage of contrast material. Journal of Vascular and Interventional Radiology 2003 14, 489-492DOI: (10.1097/01.RVI.0000064852.87207.0B) Copyright © 2003 Society of Interventional Radiology Terms and Conditions
Figure 4 Follow-up US of the left kidney at 26 weeks reveals a shrunken kidney, with dilatation of the collecting system, but no evidence of a residual tumor. Journal of Vascular and Interventional Radiology 2003 14, 489-492DOI: (10.1097/01.RVI.0000064852.87207.0B) Copyright © 2003 Society of Interventional Radiology Terms and Conditions